why choose us

First received: August 04, 2023

Clinical Trial: Safety, Tolerability, and Pharmacokinetics of CSX-1004

Study Status: Completed

Recruit Status: RECRUITING

Condition: Opioid Overdose

Study Type: INTERVENTIONAL


Official Title: A Phase 1a, Randomized, Double-Blind, Placebo-Controlled, Single Site, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of CSX-1004 Injection in Healthy Adults

Brief Summary: This is a Phase 1a, randomized, double-blind, single ascending dose study, designed to assess the safety, tolerability, and PK of a single CSX-1004 injection, administered by IV infusion across a range of doses in healthy adult subjects.The study will have 3 phases: Screening, Inpatient Treatment, and Outpatient Follow-up.The primary objective of the study is to determine the safety and tolerability of CSX-1004 Injection administered by intravenous (IV) infusion across a range of doses in healthy adult…

Read more